| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/08/1998 | CN1186680A High effect nontoxic natural anti-cancer agent |
| 07/08/1998 | CN1039012C Novel phospholipid derivatives |
| 07/07/1998 | US5777139 Taxoids, their preparation and pharmaceutical compositions containing them |
| 07/07/1998 | US5776978 Pharmaceutical preparations containing polyunsaturated fatty acids, their esters or salts, together with antioxidant vitamins or provitamins |
| 07/07/1998 | US5776977 Arylcycloalkyl derivatives, their production and their use |
| 07/07/1998 | US5776962 Lactone compounds for treating patient with precancerous lesions |
| 07/07/1998 | US5776947 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock |
| 07/07/1998 | US5776925 Texaphyrins |
| 07/07/1998 | US5776913 Therapeutic diet for metabolic abnormalities found in animals with lymphoma |
| 07/07/1998 | US5776903 Replacing peptide bond with phosphine bond |
| 07/07/1998 | US5776759 Polynucleotide sequences |
| 07/07/1998 | US5776753 Human peroxisomal thioesterase |
| 07/07/1998 | US5776746 Efficient isolation of amplified cell lines which express theproteins of interest in a relatively short period of time |
| 07/07/1998 | US5776743 Method of sensitizing tumor cells with adenovirus E1A |
| 07/07/1998 | US5776732 Isolated, purified polynucleotide sequence encoding a polypeptide |
| 07/07/1998 | US5776704 Method of detecting angiogenic protein |
| 07/07/1998 | US5776456 Administering a polypeptide |
| 07/07/1998 | US5776451 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/07/1998 | US5776427 Methods for targeting the vasculature of solid tumors |
| 07/07/1998 | US5776095 Pretargeting noncanerous cells or tissues with a cytoprotective agents before therapy with radiation or anticarcinogenic agents |
| 07/07/1998 | US5776094 Method and kit for imaging and treating organs and tissues |
| 07/07/1998 | US5776093 Method for imaging and treating organs and tissues |
| 07/07/1998 | CA2117891C Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent |
| 07/07/1998 | CA2093914C Antineoplastic drug of plant extraction and process for the preparation thereof |
| 07/07/1998 | CA1339947C Peptide compounds |
| 07/02/1998 | WO1998028625A1 Method for diagnosis and therapy of hodgkin lymphomas |
| 07/02/1998 | WO1998028621A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | WO1998028445A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | WO1998028442A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | WO1998028336A1 Polysaccharide-peptide derivatives |
| 07/02/1998 | WO1998028334A1 Peptide antagonists of dp transcription factors |
| 07/02/1998 | WO1998028317A2 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | WO1998028305A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028304A1 Pro-drugs and counterparts of camptothecin, their application as medicines |
| 07/02/1998 | WO1998028303A1 METHOD AND DEVICE FOR PRODUCTION OF LYOPHILIZED HYDROCHLORIDE-1β,10β-EPOXY-13-DIMETHYLAMINO-GUAIA-3(4)-EN-6,12-OLIDE |
| 07/02/1998 | WO1998028288A1 6-thio-substituted paclitaxels |
| 07/02/1998 | WO1998028281A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| 07/02/1998 | WO1998027994A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | WO1998027992A1 Antitumor active substances |
| 07/02/1998 | WO1998014445A3 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 07/02/1998 | CA2276090A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | CA2275964A1 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | CA2275483A1 Polysaccharide-peptide derivatives |
| 07/02/1998 | CA2274734A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | CA2274675A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | CA2274586A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | CA2272855A1 Method of diagnosis and therapy of hodgkin's lymphomas |
| 07/02/1998 | CA2271715A1 Peptide antagonists of dp transcription factors |
| 07/02/1998 | CA2268774A1 6-thio-substituted paclitaxels |
| 07/01/1998 | EP0850940A1 Ellipticine derivatives, their preparation and pharmaceutical compositions containing them |
| 07/01/1998 | EP0850939A1 Ellipticine derivatives, their preparation and pharmaceutical compositions containing them |
| 07/01/1998 | EP0850319A1 Method for modulating cell apoptosis |
| 07/01/1998 | EP0850316A1 Cryptophycins from aberrant biosynthesis |
| 07/01/1998 | EP0850300A1 Method of modulating gene expression with reduced immunostimulatory response |
| 07/01/1998 | EP0850250A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | EP0850233A1 Retinoids and methods of use of same |
| 07/01/1998 | EP0850224A1 Radiation-activated cytotoxin therapy |
| 07/01/1998 | EP0850222A1 Piperazine derivatives and process for the preparation thereof |
| 07/01/1998 | EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/01/1998 | EP0850220A1 Cyclopropylindoles and their seco precursors, and their use as prodrugs |
| 07/01/1998 | EP0850071A1 Gene therapy for effector cell regulation |
| 07/01/1998 | EP0850067A1 Method for treating cancers using 6- 3- 1-adamantyl]-4-hydroxyphenyl] |
| 07/01/1998 | EP0850062A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 07/01/1998 | EP0850057A1 Pharmaceutical compounds |
| 07/01/1998 | EP0850056A1 Topical anti-skin-cancer preparations |
| 07/01/1998 | EP0721352A4 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 07/01/1998 | EP0695308B1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 07/01/1998 | EP0646127B1 Polypeptide bombesin antagonists |
| 07/01/1998 | EP0639183B1 Nitrogen oxides of aza- and diaza-anthracenedione derivatives, their preparation and their use as antitumor agents |
| 07/01/1998 | EP0594581B1 Production of glycosides, especially of steroidal glycosides |
| 07/01/1998 | EP0546124B1 Multidomain hematopoiesis stimulators |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186443A Radiolabeled peptides for diagnosis and therapy |
| 07/01/1998 | CN1186440A Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| 07/01/1998 | CN1186435A Use of vitamin D4 derivatives for treating cancer |
| 07/01/1998 | CN1186433A Use of benzimidazoles for manufacturing medicament for treatment of leukemia |
| 07/01/1998 | CN1186074A New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them |
| 07/01/1998 | CN1185948A Inhibitor for generation of 3-deoxyglucurone |
| 07/01/1998 | CN1185945A Anti-cancer microballs and manufacture thereof |
| 07/01/1998 | CN1185904A Composition for feed use, comprising lyothilized live lactic bacteria |
| 07/01/1998 | CN1038929C Chelants processing ortho ligating functionality and complexes thereof |
| 07/01/1998 | CN1038904C Preparation of megestrol acetate |
| 06/30/1998 | US5773646 Integrin inhibitors |
| 06/30/1998 | US5773644 Cyclopropyl alkanoic acid derivatives |
| 06/30/1998 | US5773609 In vivo target tissue selectivity |
| 06/30/1998 | US5773586 Conjugates comprising truncated keratinocyte growth factor (KGF) having increased biological activity and a toxin |
| 06/30/1998 | US5773582 Tumor necrosis factor muteins |
| 06/30/1998 | US5773581 Acid stable substance dervived from naturally occuring granulocyte colony stimulating factor |
| 06/30/1998 | US5773580 Human protein kinase c inhibitor homolog |
| 06/30/1998 | US5773579 Comprising a membrane ion and a phosphorylation site; exhibits carbonic anhydrase activity |
| 06/30/1998 | US5773571 Peptide nucleic acids |
| 06/30/1998 | US5773461 Antitumor agents |
| 06/30/1998 | US5773455 Inhibitors of prenyl transferases |
| 06/30/1998 | US5773438 Synthetic matrix metalloprotease inhibitors and use thereof |
| 06/30/1998 | US5773414 Endothelin antagonists |
| 06/30/1998 | US5773292 Ablate or kill cancer cells |